<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6807-1-1.anc" start="10092" end="10099" sStart="-1" offset="0" sid="null" wn="2" wnkey="success%1:04:00::" annotator="veweser" text="Our approach enabled the discovery ab initio of RAR agonists displaying some activity at 50 nM with a 7% &lt;b&gt;success&lt;/b&gt; &lt;b&gt;rate&lt;/b&gt;." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6807-1-1.anc" start="10092" end="10099" sStart="null" offset="0" sid="null" wn="1" wnkey="success%1:11:00::" annotator="cgozo" text="Our approach enabled the discovery ab initio of RAR agonists displaying some activity at 50 nM with a 7% &lt;b&gt;success&lt;/b&gt; &lt;b&gt;rate&lt;/b&gt;." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6807-1-1.anc" start="10092" end="10099" sStart="null" offset="0" sid="null" wn="1" wnkey="success%1:11:00::" annotator="brubin" text="Our approach enabled the discovery ab initio of RAR agonists displaying some activity at 50 nM with a 7% &lt;b&gt;success&lt;/b&gt; &lt;b&gt;rate&lt;/b&gt;." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6807-1-1.anc" start="3301" end="3306" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" annotator="veweser" text="A &lt;b&gt;rapid&lt;/b&gt; docking procedure with flexible ligand and a grid representation of the receptor was followed by an extensive Monte Carlo energy minimization with both ligand and receptor side chains flexible (see &quot;Materials and Methods&quot; for details)." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6807-1-1.anc" start="11454" end="11459" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" annotator="veweser" text="This report details the &lt;b&gt;rapid&lt;/b&gt; discovery of RAR agonists with novel structural features, thanks to a powerful virtual ligand screening approach, and a research strategy where considerations on existing ligands are avoided." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6807-1-1.anc" start="13087" end="13092" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" annotator="veweser" text="This &lt;b&gt;rapid&lt;/b&gt; docking procedure was followed by a more refined energy minimization of the complex, with a full atom representation of the receptor, and flexible receptor side chains, according to the ICM stochastic global optimization algorithm [ 26, 27] as implemented in the Molsoft ICM 2.7 program [ 17]." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6807-1-1.anc" start="3301" end="3306" sStart="null" offset="0" sid="null" wn="2" wnkey="rapid%5:00:02:fast:01" annotator="tofox" text="A &lt;b&gt;rapid&lt;/b&gt; docking procedure with flexible ligand and a grid representation of the receptor was followed by an extensive Monte Carlo energy minimization with both ligand and receptor side chains flexible (see &quot;Materials and Methods&quot; for details)." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6807-1-1.anc" start="11454" end="11459" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" annotator="carichter" text="This report details the &lt;b&gt;rapid&lt;/b&gt; discovery of RAR agonists with novel structural features, thanks to a powerful virtual ligand screening approach, and a research strategy where considerations on existing ligands are avoided." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6807-1-1.anc" start="13087" end="13092" sStart="null" offset="0" sid="null" wn="1 2" wnkey="null" annotator="carichter" text="This &lt;b&gt;rapid&lt;/b&gt; docking procedure was followed by a more refined energy minimization of the complex, with a full atom representation of the receptor, and flexible receptor side chains, according to the ICM stochastic global optimization algorithm [ 26, 27] as implemented in the Molsoft ICM 2.7 program [ 17]." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6807-1-1.anc" start="16962" end="16968" sStart="null" offset="8" sid="r8.number.n.0612" wn="8" wnkey="number%1:10:02::" annotator="cgozo" text="Catalog number S08503-1)." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6807-1-1.anc" start="4398" end="4402" sStart="null" offset="2" sid="r10.high.j.0929" wn="1" wnkey="high%3:00:02::" annotator="veweser" text="A high throughput virtual screening was carried out on the Available Chemicals Directory (MDL Information Systems, San Leandro, CA), a compound structure database of over 150,000 molecules." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6807-1-1.anc" start="15981" end="15985" sStart="null" offset="110" sid="r9.full.j.0348" wn="2" wnkey="full%5:00:01:whole:00" annotator="brubin" text="HeLa cells were transfected by calcium phosphate precipitation using 1 ?g of plasmid expressing the full length receptor isoform and 1 ?g of a ?MTV-IR-CAT reporter gene, as previously described [ 22, 23]." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6807-1-1.anc" start="6811" end="6815" sStart="null" offset="37" sid="r9.full.j.0842" wn="2" wnkey="full%5:00:01:whole:00" annotator="anfahmy" text="At 20 ?M, agonist 1 induced full activation of RAR-? and RAR-?, and 80% activation of RAR-?, showing that this compound is a full agonist." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6807-1-1.anc" start="1734" end="1741" sStart="null" offset="113" sid="r10.control.n.0115" wn="2" wnkey="control%1:24:00::" annotator="cgozo" text="An increasing amount of data suggests that the RAR-? isoform, which is under the transcriptional control of RAR-?, is involved in suppressing cell growth and tumorigenicity [ 11, 12, 13, 14, 15, 16]." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6807-1-1.anc" start="12836" end="12847" sStart="null" offset="38" sid="r11.combination.n.0544" wn="1" wnkey="combination%1:14:00::" annotator="vebatchelder" text="The flexible ligand was docked into a combination of five potential map representations of the RAR-? ligand binding pocket, which account for two Van der Waals boundaries, hydrophobicity, electrostatics and hydrogen bonding profiles [ 20, 27]." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6807-1-1.anc" start="13881" end="13892" sStart="null" offset="238" sid="r11.combination.n.0587" wn="1" wnkey="combination%1:14:00::" annotator="anfahmy" text="The procedure followed was similar than previously described [ 8]: each flexible ligand of the Available Chemicals Directory (MDL Information Systems, San Leandro) was docked automatically into the combination of potential maps described above, and assigned a score according to its fit with the receptor." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6807-1-1.anc" start="1216" end="1227" sStart="null" offset="95" sid="r11.combination.n.0075" wn="1" wnkey="combination%1:14:00::" annotator="anfahmy" text="Several retinoid and non-retinoid ligands have been described, which activate one or a combination of RAR isoforms." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6807-1-1.anc" start="1216" end="1227" sStart="null" offset="95" sid="r11.combination.n.0075" wn="1" wnkey="combination%1:14:00::" annotator="adelpriore" text="Several retinoid and non-retinoid ligands have been described, which activate one or a combination of RAR isoforms." />
  </sentences>
</list>